Metacrine

• NCT04702490

  Phase 2, Status unknown, 120 people, 11 Jan 2021

• Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

  Grants or research support, 10 Oct 2022

• Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial

  Grants or research support, 11 Jan 2022

• Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial

  Grants or research support, 6 Aug 2021

Sources: pubmed.ncbi.nlm.nih.gov